AETHLON MEDICAL, INC. Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested in Period, Fair Value
AETHLON MEDICAL, INC. (AEMD) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested in Period, Fair Value of $278.55 thousand for the 12-month period ending 2026-03-31, per its 10-K filed 2026-06-10.
Financial Statements › Notes › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Additional Disclosures
us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1 · last filed 2026-06-10
- AETHLON MEDICAL, INC. share-based compensation arrangement by share-based payment award, options, vested in period, fair value for the quarter ending 2025-03-31 was $72.44K, a 47.93% decline year-over-year.
- AETHLON MEDICAL, INC. share-based compensation arrangement by share-based payment award, options, vested in period, fair value for the quarter ending 2024-12-31 was $89.97K, a 84.30% decline year-over-year.
- AETHLON MEDICAL, INC. share-based compensation arrangement by share-based payment award, options, vested in period, fair value for the quarter ending 2024-09-30 was $113.49K, a 55.87% decline year-over-year.
- AETHLON MEDICAL, INC. share-based compensation arrangement by share-based payment award, options, vested in period, fair value for the quarter ending 2024-06-30 was $139.33K, a 44.29% decline year-over-year.
- AETHLON MEDICAL, INC. share-based compensation arrangement by share-based payment award, options, vested in period, fair value for fiscal 2026 was $278.55K, a 32.92% decline from fiscal 2025.
- AETHLON MEDICAL, INC. share-based compensation arrangement by share-based payment award, options, vested in period, fair value for fiscal 2025 was $415.23K, a 65.95% decline from fiscal 2024.
- AETHLON MEDICAL, INC. share-based compensation arrangement by share-based payment award, options, vested in period, fair value for fiscal 2024 was $1.22M, a 15.92% increase from fiscal 2023.
- AETHLON MEDICAL, INC. share-based compensation arrangement by share-based payment award, options, vested in period, fair value for fiscal 2023 was $1.05M, a 40.14% increase from fiscal 2022.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested in Period, Fair Value 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested in Period, Fair Value 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested in Period, Fair Value 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested in Period, Fair Value 12 month |
|---|---|---|---|---|
| 2026-03-31 | $278.55K 10-K · filed 2026-06-10 | |||
| 2025-03-31 | $72.44K derived: 10-K 12 month − 10-Q 9 month · filed 2026-06-10 | $162.41K derived: sum of 2 quarters · filed 2026-06-10 | $275.91K derived: sum of 3 quarters · filed 2026-06-10 | $415.23K 10-K · filed 2026-06-10 |
| 2024-12-31 | $89.97K 10-Q · filed 2025-02-12 | $203.46K derived: sum of 2 quarters · filed 2025-02-12 | $342.79K 10-Q · filed 2025-02-12 | $481.91K derived: sum of 4 quarters · filed 2025-06-26 |
| 2024-09-30 | $113.49K 10-Q · filed 2024-11-13 | $252.82K 10-Q · filed 2024-11-13 | $391.94K derived: sum of 3 quarters · filed 2025-06-26 | $964.90K derived: sum of 4 quarters · filed 2025-06-26 |
| 2024-06-30 | $139.33K 10-Q · filed 2024-08-14 | $278.45K derived: sum of 2 quarters · filed 2025-06-26 | $851.40K derived: sum of 3 quarters · filed 2025-06-26 | $1.11M derived: sum of 4 quarters · filed 2025-06-26 |
| 2024-03-31 | $139.12K derived: 10-K 12 month − 10-Q 9 month · filed 2025-06-26 | $712.08K derived: sum of 2 quarters · filed 2025-06-26 | $969.26K derived: sum of 3 quarters · filed 2025-06-26 | $1.22M 10-K · filed 2025-06-26 |
| 2023-12-31 | $572.96K 10-Q · filed 2025-02-12 | $830.14K derived: sum of 2 quarters · filed 2025-02-12 | $1.08M 10-Q · filed 2025-02-12 | $1.34M derived: sum of 4 quarters · filed 2025-02-12 |
| 2023-09-30 | $257.18K 10-Q · filed 2024-11-13 | $507.30K 10-Q · filed 2024-11-13 | $767.61K derived: sum of 3 quarters · filed 2024-11-13 | $1.03M derived: sum of 4 quarters · filed 2024-11-13 |
| 2023-06-30 | $250.11K 10-Q · filed 2024-08-14 | $510.42K derived: sum of 2 quarters · filed 2024-08-14 | $773.04K derived: sum of 3 quarters · filed 2024-08-14 | $1.09M derived: sum of 4 quarters · filed 2024-08-14 |
| 2023-03-31 | $260.31K derived: 10-K 12 month − 10-Q 9 month · filed 2024-06-27 | $522.92K derived: sum of 2 quarters · filed 2024-06-27 | $836.46K derived: sum of 3 quarters · filed 2024-06-27 | $1.05M 10-K · filed 2024-06-27 |
| 2022-12-31 | $262.61K 10-Q · filed 2024-02-14 | $576.15K derived: sum of 2 quarters · filed 2024-02-14 | $791.59K 10-Q · filed 2024-02-14 | $1.02M derived: sum of 4 quarters · filed 2024-02-14 |
| 2022-09-30 | $313.54K 10-Q · filed 2023-11-14 | $528.98K 10-Q · filed 2023-11-14 | $757.36K derived: sum of 3 quarters · filed 2023-11-14 | $958.38K derived: sum of 4 quarters · filed 2023-11-14 |
| 2022-06-30 | $215.44K 10-Q · filed 2023-08-10 | $443.82K derived: sum of 2 quarters · filed 2023-08-10 | $644.84K derived: sum of 3 quarters · filed 2023-08-10 | |
| 2022-03-31 | $228.39K derived: 10-K 12 month − 10-Q 9 month · filed 2023-06-28 | $429.41K derived: sum of 2 quarters · filed 2023-06-28 | $750.62K 10-K · filed 2023-06-28 | |
| 2021-12-31 | $201.02K 10-Q · filed 2023-02-13 | $522.23K 10-Q · filed 2023-02-13 | ||
| 2014-03-31 | $384.60K derived: 10-K 12 month − 10-Q 9 month · filed 2014-07-15 | $417.35K derived: sum of 2 quarters · filed 2014-07-15 | $491.20K derived: sum of 3 quarters · filed 2014-07-15 | $541.59K 10-K · filed 2014-07-15 |
| 2013-12-31 | $32.75K 10-Q · filed 2014-02-11 | $106.61K derived: sum of 2 quarters · filed 2014-02-11 | $156.99K 10-Q · filed 2014-02-11 | $254.10K derived: sum of 4 quarters · filed 2014-07-15 |
| 2013-09-30 | $73.86K 10-Q · filed 2013-11-14 | $124.24K 10-Q · filed 2013-11-14 | $221.35K derived: sum of 3 quarters · filed 2014-07-15 | $298.77K derived: sum of 4 quarters · filed 2014-07-15 |
| 2013-06-30 | $50.39K 10-Q · filed 2013-08-13 | $147.50K derived: sum of 2 quarters · filed 2014-07-15 | $224.92K derived: sum of 3 quarters · filed 2014-07-15 | $353.49K derived: sum of 4 quarters · filed 2014-07-15 |
| 2013-03-31 | $97.11K derived: 10-K 12 month − 10-Q 9 month · filed 2014-07-15 | $174.53K derived: sum of 2 quarters · filed 2014-07-15 | $303.10K derived: sum of 3 quarters · filed 2014-07-15 | $355.58K 10-K · filed 2014-07-15 |
| 2012-12-31 | $77.42K 10-Q · filed 2014-02-11 | $205.99K derived: sum of 2 quarters · filed 2014-02-11 | $258.47K 10-Q · filed 2014-02-11 | |
| 2012-09-30 | $128.57K 10-Q · filed 2013-11-14 | $181.05K 10-Q · filed 2013-11-14 | ||
| 2012-06-30 | $52.79K 10-Q · filed 2013-08-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Bluejay Diagnostics, Inc. (BJDX) | United States | $0.004B | |
| INTELLIGENT BIO SOLUTIONS INC. (INBS) | United States | $0.005B | |
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| Sonoma Pharmaceuticals, Inc. (SNOA) | United States | $0.006B | -2.59 |
| enVVeno Medical Corp (NVNO) | United States | $0.006B | -0.48 |
| Beyond Air, Inc. (XAIR) | United States | $0.003B | -0.01 |
| Vivos Therapeutics, Inc. (VVOS) | United States | $0.003B | -0.26 |
| Co-Diagnostics, Inc. (CODX) | United States | $0.007B | -0.32 |